ZA200006613B

ZA200006613B - Mechanical stress induced genes, expression products therefrom, and uses thereof.

Mechanical stress induced genes, expression products therefrom, and uses thereof. Download PDF

Info

Publication number: ZA200006613B
Authority: ZA; South Africa
Prior art keywords: protein; gene; mrna; cells; bone
Prior art date: 1998-05-15

Application number

ZA200006613A

Other languages

English (en)

Inventor

Paz Einat

Rami Skaliter

Alexander Faerman

Orna Mor

Elena Feinstein

Original Assignee

Quark Biotech Inc

Priority date

1998-05-15

Filing date

2000-11-14

Publication date

2002-02-14

2000-11-14 Application filed by Quark Biotech Inc filed Critical Quark Biotech Inc

2002-02-14 Publication of ZA200006613B publication Critical patent/ZA200006613B/en

Links

108090000623 proteins and genes Proteins 0.000 title claims abstract description 738
230000014509 gene expression Effects 0.000 title claims abstract description 211
238000000034 method Methods 0.000 claims abstract description 308
208000001132 Osteoporosis Diseases 0.000 claims abstract description 125
239000000523 sample Substances 0.000 claims abstract description 91
239000000203 mixture Substances 0.000 claims abstract description 86
238000011282 treatment Methods 0.000 claims abstract description 76
230000008569 process Effects 0.000 claims abstract description 28
238000012360 testing method Methods 0.000 claims abstract description 18
210000004027 cell Anatomy 0.000 claims description 355
102000004169 proteins and genes Human genes 0.000 claims description 293
108020004999 messenger RNA Proteins 0.000 claims description 262
210000000988 bone and bone Anatomy 0.000 claims description 192
238000009396 hybridization Methods 0.000 claims description 83
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 77
150000007523 nucleic acids Chemical class 0.000 claims description 76
230000001105 regulatory effect Effects 0.000 claims description 75
210000001519 tissue Anatomy 0.000 claims description 72
241000124008 Mammalia Species 0.000 claims description 65
239000003814 drug Substances 0.000 claims description 63
102000039446 nucleic acids Human genes 0.000 claims description 62
108020004707 nucleic acids Proteins 0.000 claims description 62
239000013598 vector Substances 0.000 claims description 56
210000002449 bone cell Anatomy 0.000 claims description 55
230000000694 effects Effects 0.000 claims description 55
210000000963 osteoblast Anatomy 0.000 claims description 53
108090000765 processed proteins & peptides Proteins 0.000 claims description 52
230000007423 decrease Effects 0.000 claims description 49
229920001184 polypeptide Polymers 0.000 claims description 49
102000004196 processed proteins & peptides Human genes 0.000 claims description 49
238000004458 analytical method Methods 0.000 claims description 41
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 39
201000010099 disease Diseases 0.000 claims description 36
230000037182 bone density Effects 0.000 claims description 35
239000012634 fragment Substances 0.000 claims description 33
230000035772 mutation Effects 0.000 claims description 29
238000013519 translation Methods 0.000 claims description 29
108091028043 Nucleic acid sequence Proteins 0.000 claims description 28
238000001415 gene therapy Methods 0.000 claims description 26
230000004048 modification Effects 0.000 claims description 26
238000012986 modification Methods 0.000 claims description 26
238000012217 deletion Methods 0.000 claims description 25
230000037430 deletion Effects 0.000 claims description 25
108700028146 Genetic Enhancer Elements Proteins 0.000 claims description 23
230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 23
208000024891 symptom Diseases 0.000 claims description 23
238000000338 in vitro Methods 0.000 claims description 22
230000004481 post-translational protein modification Effects 0.000 claims description 22
239000000262 estrogen Substances 0.000 claims description 21
229940011871 estrogen Drugs 0.000 claims description 20
238000001727 in vivo Methods 0.000 claims description 20
125000003729 nucleotide group Chemical group 0.000 claims description 20
238000002360 preparation method Methods 0.000 claims description 20
210000001612 chondrocyte Anatomy 0.000 claims description 19
239000002773 nucleotide Substances 0.000 claims description 19
238000013518 transcription Methods 0.000 claims description 19
230000035897 transcription Effects 0.000 claims description 19
230000001276 controlling effect Effects 0.000 claims description 18
230000001939 inductive effect Effects 0.000 claims description 17
230000001413 cellular effect Effects 0.000 claims description 16
150000001875 compounds Chemical class 0.000 claims description 16
230000002068 genetic effect Effects 0.000 claims description 16
238000010367 cloning Methods 0.000 claims description 15
108020005544 Antisense RNA Proteins 0.000 claims description 14
239000003184 complementary RNA Substances 0.000 claims description 13
210000000805 cytoplasm Anatomy 0.000 claims description 13
239000002243 precursor Substances 0.000 claims description 13
238000011160 research Methods 0.000 claims description 13
108090000144 Human Proteins Proteins 0.000 claims description 12
102000003839 Human Proteins Human genes 0.000 claims description 12
238000013459 approach Methods 0.000 claims description 11
230000000295 complement effect Effects 0.000 claims description 10
230000007613 environmental effect Effects 0.000 claims description 10
210000004698 lymphocyte Anatomy 0.000 claims description 8
230000002188 osteogenic effect Effects 0.000 claims description 8
230000002648 chondrogenic effect Effects 0.000 claims description 7
238000012163 sequencing technique Methods 0.000 claims description 7
238000000018 DNA microarray Methods 0.000 claims description 4
239000003112 inhibitor Substances 0.000 claims description 4
230000014461 bone development Effects 0.000 claims description 3
230000002265 prevention Effects 0.000 abstract description 19
238000003745 diagnosis Methods 0.000 abstract description 3
239000000047 product Substances 0.000 description 97
230000035882 stress Effects 0.000 description 92
241000700159 Rattus Species 0.000 description 56
108020004414 DNA Proteins 0.000 description 43
239000002299 complementary DNA Substances 0.000 description 42
230000000875 corresponding effect Effects 0.000 description 42
108091034117 Oligonucleotide Proteins 0.000 description 41
239000011575 calcium Substances 0.000 description 38
239000013615 primer Substances 0.000 description 37
241000282414 Homo sapiens Species 0.000 description 31
210000002997 osteoclast Anatomy 0.000 description 31
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 29
238000003752 polymerase chain reaction Methods 0.000 description 29
230000014616 translation Effects 0.000 description 29
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 28
229910052791 calcium Inorganic materials 0.000 description 28
239000000872 buffer Substances 0.000 description 25
230000015572 biosynthetic process Effects 0.000 description 24
230000006870 function Effects 0.000 description 23
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 22
101710115889 Immunoglobulin superfamily member 10 Proteins 0.000 description 21
229910052500 inorganic mineral Inorganic materials 0.000 description 19
235000010755 mineral Nutrition 0.000 description 19
239000011707 mineral Substances 0.000 description 19
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 18
210000002729 polyribosome Anatomy 0.000 description 18
241001465754 Metazoa Species 0.000 description 17
210000004379 membrane Anatomy 0.000 description 17
239000012528 membrane Substances 0.000 description 17
210000004940 nucleus Anatomy 0.000 description 17
230000004044 response Effects 0.000 description 17
102100021033 Immunoglobulin superfamily member 10 Human genes 0.000 description 16
229930006000 Sucrose Natural products 0.000 description 16
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 16
239000000499 gel Substances 0.000 description 16
238000007901 in situ hybridization Methods 0.000 description 16
239000005720 sucrose Substances 0.000 description 16
230000003321 amplification Effects 0.000 description 15
230000033228 biological regulation Effects 0.000 description 15
210000001185 bone marrow Anatomy 0.000 description 15
238000006243 chemical reaction Methods 0.000 description 15
238000011161 development Methods 0.000 description 15
230000018109 developmental process Effects 0.000 description 15
230000001965 increasing effect Effects 0.000 description 15
239000011159 matrix material Substances 0.000 description 15
238000003199 nucleic acid amplification method Methods 0.000 description 15
230000011164 ossification Effects 0.000 description 15
239000008188 pellet Substances 0.000 description 15
230000000638 stimulation Effects 0.000 description 15
239000006228 supernatant Substances 0.000 description 15
239000003981 vehicle Substances 0.000 description 15
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
125000003275 alpha amino acid group Chemical group 0.000 description 14
238000001514 detection method Methods 0.000 description 14
230000004069 differentiation Effects 0.000 description 14
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 14
238000002955 isolation Methods 0.000 description 14
150000003180 prostaglandins Chemical class 0.000 description 14
206010065687 Bone loss Diseases 0.000 description 13
102000008299 Nitric Oxide Synthase Human genes 0.000 description 13
108010021487 Nitric Oxide Synthase Proteins 0.000 description 13
150000001413 amino acids Chemical class 0.000 description 13
XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 13
239000007788 liquid Substances 0.000 description 13
238000004519 manufacturing process Methods 0.000 description 13
239000013603 viral vector Substances 0.000 description 13
238000004113 cell culture Methods 0.000 description 12
230000001419 dependent effect Effects 0.000 description 12
229960002986 dinoprostone Drugs 0.000 description 12
230000001575 pathological effect Effects 0.000 description 12
XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 12
239000000243 solution Substances 0.000 description 12
238000003786 synthesis reaction Methods 0.000 description 12
230000003827 upregulation Effects 0.000 description 12
241000699666 Mus <mouse, genus> Species 0.000 description 11
238000003556 assay Methods 0.000 description 11
229940079593 drug Drugs 0.000 description 11
208000015181 infectious disease Diseases 0.000 description 11
239000013612 plasmid Substances 0.000 description 11
102000005962 receptors Human genes 0.000 description 11
108020003175 receptors Proteins 0.000 description 11
241000894007 species Species 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
230000027455 binding Effects 0.000 description 10
210000000845 cartilage Anatomy 0.000 description 10
229920001436 collagen Polymers 0.000 description 10
230000006698 induction Effects 0.000 description 10
210000003734 kidney Anatomy 0.000 description 10
238000007899 nucleic acid hybridization Methods 0.000 description 10
239000000126 substance Substances 0.000 description 10
102000004190 Enzymes Human genes 0.000 description 9
108090000790 Enzymes Proteins 0.000 description 9
108010051335 Lipocalin-2 Proteins 0.000 description 9
102000013519 Lipocalin-2 Human genes 0.000 description 9
238000005194 fractionation Methods 0.000 description 9
239000007943 implant Substances 0.000 description 9
239000002609 medium Substances 0.000 description 9
238000007634 remodeling Methods 0.000 description 9
239000007787 solid Substances 0.000 description 9
230000001225 therapeutic effect Effects 0.000 description 9
238000002560 therapeutic procedure Methods 0.000 description 9
108050000156 vitamin D receptors Proteins 0.000 description 9
108010035532 Collagen Proteins 0.000 description 8
108050009340 Endothelin Proteins 0.000 description 8
102000002045 Endothelin Human genes 0.000 description 8
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 8
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 8
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
206010017076 Fracture Diseases 0.000 description 8
206010020100 Hip fracture Diseases 0.000 description 8
108020003217 Nuclear RNA Proteins 0.000 description 8
102100036034 Thrombospondin-1 Human genes 0.000 description 8
238000007792 addition Methods 0.000 description 8
239000000654 additive Substances 0.000 description 8
239000002671 adjuvant Substances 0.000 description 8
230000006907 apoptotic process Effects 0.000 description 8
230000008859 change Effects 0.000 description 8
230000001086 cytosolic effect Effects 0.000 description 8
210000002744 extracellular matrix Anatomy 0.000 description 8
238000011065 in-situ storage Methods 0.000 description 8
230000001009 osteoporotic effect Effects 0.000 description 8
208000001685 postmenopausal osteoporosis Diseases 0.000 description 8
102000040650 (ribonucleotides)n+m Human genes 0.000 description 7
102100033328 Ankyrin repeat domain-containing protein 42 Human genes 0.000 description 7
208000010392 Bone Fractures Diseases 0.000 description 7
102100031168 CCN family member 2 Human genes 0.000 description 7
102000008186 Collagen Human genes 0.000 description 7
102000004127 Cytokines Human genes 0.000 description 7
108090000695 Cytokines Proteins 0.000 description 7
102000003886 Glycoproteins Human genes 0.000 description 7
108090000288 Glycoproteins Proteins 0.000 description 7
101000732369 Homo sapiens Ankyrin repeat domain-containing protein 42 Proteins 0.000 description 7
102000000589 Interleukin-1 Human genes 0.000 description 7
108010002352 Interleukin-1 Proteins 0.000 description 7
241000699670 Mus sp. Species 0.000 description 7
102000043141 Nuclear RNA Human genes 0.000 description 7
240000004808 Saccharomyces cerevisiae Species 0.000 description 7
241000700605 Viruses Species 0.000 description 7
210000002257 embryonic structure Anatomy 0.000 description 7
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 7
210000000981 epithelium Anatomy 0.000 description 7
238000000605 extraction Methods 0.000 description 7
229940088597 hormone Drugs 0.000 description 7
239000005556 hormone Substances 0.000 description 7
229960000905 indomethacin Drugs 0.000 description 7
230000001404 mediated effect Effects 0.000 description 7
239000002245 particle Substances 0.000 description 7
239000002987 primer (paints) Substances 0.000 description 7
230000002062 proliferating effect Effects 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
230000004936 stimulating effect Effects 0.000 description 7
239000000725 suspension Substances 0.000 description 7
102000009310 vitamin D receptors Human genes 0.000 description 7
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
108091005660 ADAMTS1 Proteins 0.000 description 6
208000006386 Bone Resorption Diseases 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 6
108700026244 Open Reading Frames Proteins 0.000 description 6
238000012408 PCR amplification Methods 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
102000002938 Thrombospondin Human genes 0.000 description 6
108060008245 Thrombospondin Proteins 0.000 description 6
230000000692 anti-sense effect Effects 0.000 description 6
230000024279 bone resorption Effects 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 6
239000003085 diluting agent Substances 0.000 description 6
239000000839 emulsion Substances 0.000 description 6
210000002919 epithelial cell Anatomy 0.000 description 6
239000012530 fluid Substances 0.000 description 6
238000009472 formulation Methods 0.000 description 6
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
210000004349 growth plate Anatomy 0.000 description 6
230000002163 immunogen Effects 0.000 description 6
230000002401 inhibitory effect Effects 0.000 description 6
239000000463 material Substances 0.000 description 6
230000007246 mechanism Effects 0.000 description 6
238000002493 microarray Methods 0.000 description 6
238000010369 molecular cloning Methods 0.000 description 6
238000009806 oophorectomy Methods 0.000 description 6
230000001582 osteoblastic effect Effects 0.000 description 6
229910052760 oxygen Inorganic materials 0.000 description 6
229940094443 oxytocics prostaglandins Drugs 0.000 description 6
239000003755 preservative agent Substances 0.000 description 6
230000002829 reductive effect Effects 0.000 description 6
210000002784 stomach Anatomy 0.000 description 6
230000008685 targeting Effects 0.000 description 6
210000001550 testis Anatomy 0.000 description 6
239000002562 thickening agent Substances 0.000 description 6
-1 405 Chemical class 0.000 description 5
102100027398 A disintegrin and metalloproteinase with thrombospondin motifs 1 Human genes 0.000 description 5
108010085238 Actins Proteins 0.000 description 5
102000007469 Actins Human genes 0.000 description 5
102000010637 Aquaporins Human genes 0.000 description 5
102000055006 Calcitonin Human genes 0.000 description 5
108060001064 Calcitonin Proteins 0.000 description 5
206010006956 Calcium deficiency Diseases 0.000 description 5
108010028780 Complement C3 Proteins 0.000 description 5
102000016918 Complement C3 Human genes 0.000 description 5
241000588724 Escherichia coli Species 0.000 description 5
241000282412 Homo Species 0.000 description 5
206010021143 Hypoxia Diseases 0.000 description 5
206010028980 Neoplasm Diseases 0.000 description 5
102000007000 Tenascin Human genes 0.000 description 5
108010008125 Tenascin Proteins 0.000 description 5
108010046722 Thrombospondin 1 Proteins 0.000 description 5
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 5
230000004913 activation Effects 0.000 description 5
230000008468 bone growth Effects 0.000 description 5
210000002805 bone matrix Anatomy 0.000 description 5
210000004556 brain Anatomy 0.000 description 5
230000002308 calcification Effects 0.000 description 5
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 5
229960004015 calcitonin Drugs 0.000 description 5
108091092328 cellular RNA Proteins 0.000 description 5
210000001072 colon Anatomy 0.000 description 5
230000002596 correlated effect Effects 0.000 description 5
230000003828 downregulation Effects 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
239000000284 extract Substances 0.000 description 5
210000001508 eye Anatomy 0.000 description 5
230000012010 growth Effects 0.000 description 5
230000036541 health Effects 0.000 description 5
230000007954 hypoxia Effects 0.000 description 5
210000000936 intestine Anatomy 0.000 description 5
238000004137 mechanical activation Methods 0.000 description 5
230000004060 metabolic process Effects 0.000 description 5
230000003228 microsomal effect Effects 0.000 description 5
230000032258 transport Effects 0.000 description 5
230000003612 virological effect Effects 0.000 description 5
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 4
108700028369 Alleles Proteins 0.000 description 4
102100037238 E3 ubiquitin-protein ligase UBR4 Human genes 0.000 description 4
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
108010067770 Endopeptidase K Proteins 0.000 description 4
108010010803 Gelatin Proteins 0.000 description 4
101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 4
101000807547 Homo sapiens E3 ubiquitin-protein ligase UBR4 Proteins 0.000 description 4
102000004889 Interleukin-6 Human genes 0.000 description 4
108090001005 Interleukin-6 Proteins 0.000 description 4
102000003960 Ligases Human genes 0.000 description 4
108090000364 Ligases Proteins 0.000 description 4
208000029725 Metabolic bone disease Diseases 0.000 description 4
238000000636 Northern blotting Methods 0.000 description 4
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
238000002835 absorbance Methods 0.000 description 4
238000010521 absorption reaction Methods 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
238000010171 animal model Methods 0.000 description 4
210000001106 artificial yeast chromosome Anatomy 0.000 description 4
230000008901 benefit Effects 0.000 description 4
210000002798 bone marrow cell Anatomy 0.000 description 4
230000010072 bone remodeling Effects 0.000 description 4
239000002775 capsule Substances 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
108091092330 cytoplasmic RNA Proteins 0.000 description 4
102000015694 estrogen receptors Human genes 0.000 description 4
108010038795 estrogen receptors Proteins 0.000 description 4
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 4
229960005542 ethidium bromide Drugs 0.000 description 4
239000013604 expression vector Substances 0.000 description 4
239000008273 gelatin Substances 0.000 description 4
229920000159 gelatin Polymers 0.000 description 4
235000019322 gelatine Nutrition 0.000 description 4
235000011852 gelatine desserts Nutrition 0.000 description 4
230000005484 gravity Effects 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
108010044426 integrins Proteins 0.000 description 4
102000006495 integrins Human genes 0.000 description 4
230000003993 interaction Effects 0.000 description 4
229940100601 interleukin-6 Drugs 0.000 description 4
239000003446 ligand Substances 0.000 description 4
210000004185 liver Anatomy 0.000 description 4
239000003550 marker Substances 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
238000010208 microarray analysis Methods 0.000 description 4
210000001589 microsome Anatomy 0.000 description 4
210000001672 ovary Anatomy 0.000 description 4
239000012188 paraffin wax Substances 0.000 description 4
230000036961 partial effect Effects 0.000 description 4
230000008506 pathogenesis Effects 0.000 description 4
230000007170 pathology Effects 0.000 description 4
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
239000006187 pill Substances 0.000 description 4
210000003705 ribosome Anatomy 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
230000008961 swelling Effects 0.000 description 4
239000003826 tablet Substances 0.000 description 4
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 4
210000001541 thymus gland Anatomy 0.000 description 4
210000002303 tibia Anatomy 0.000 description 4
230000007306 turnover Effects 0.000 description 4
241000701447 unidentified baculovirus Species 0.000 description 4
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 3
102100022015 Alpha-1-syntrophin Human genes 0.000 description 3
108010063290 Aquaporins Proteins 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
102000000584 Calmodulin Human genes 0.000 description 3
108010041952 Calmodulin Proteins 0.000 description 3
108010022452 Collagen Type I Proteins 0.000 description 3
102000012422 Collagen Type I Human genes 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 3
108010039419 Connective Tissue Growth Factor Proteins 0.000 description 3
239000003155 DNA primer Substances 0.000 description 3
108010087894 Fatty acid desaturases Proteins 0.000 description 3
102000013366 Filamin Human genes 0.000 description 3
108060002900 Filamin Proteins 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
101000775053 Homo sapiens Neuroblast differentiation-associated protein AHNAK Proteins 0.000 description 3
102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
108010052285 Membrane Proteins Proteins 0.000 description 3
241000699660 Mus musculus Species 0.000 description 3
102100031837 Neuroblast differentiation-associated protein AHNAK Human genes 0.000 description 3
102000007999 Nuclear Proteins Human genes 0.000 description 3
108010089610 Nuclear Proteins Proteins 0.000 description 3
102100039306 Nucleotide pyrophosphatase Human genes 0.000 description 3
102000004316 Oxidoreductases Human genes 0.000 description 3
108090000854 Oxidoreductases Proteins 0.000 description 3
208000006735 Periostitis Diseases 0.000 description 3
238000002105 Southern blotting Methods 0.000 description 3
102100028897 Stearoyl-CoA desaturase Human genes 0.000 description 3
108010006785 Taq Polymerase Proteins 0.000 description 3
102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
230000009471 action Effects 0.000 description 3
230000000996 additive effect Effects 0.000 description 3
239000011543 agarose gel Substances 0.000 description 3
230000003262 anti-osteoporosis Effects 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
239000012472 biological sample Substances 0.000 description 3
229960002685 biotin Drugs 0.000 description 3
235000020958 biotin Nutrition 0.000 description 3
239000011616 biotin Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
230000037396 body weight Effects 0.000 description 3
238000010804 cDNA synthesis Methods 0.000 description 3
239000003086 colorant Substances 0.000 description 3
210000002808 connective tissue Anatomy 0.000 description 3
230000001054 cortical effect Effects 0.000 description 3
230000006866 deterioration Effects 0.000 description 3
229960003957 dexamethasone Drugs 0.000 description 3
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
210000003275 diaphysis Anatomy 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
239000006185 dispersion Substances 0.000 description 3
210000003027 ear inner Anatomy 0.000 description 3
238000001962 electrophoresis Methods 0.000 description 3
239000003623 enhancer Substances 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
210000002745 epiphysis Anatomy 0.000 description 3
210000002950 fibroblast Anatomy 0.000 description 3
239000000796 flavoring agent Substances 0.000 description 3
238000007710 freezing Methods 0.000 description 3
230000008014 freezing Effects 0.000 description 3
238000007429 general method Methods 0.000 description 3
239000003862 glucocorticoid Substances 0.000 description 3
229960003180 glutathione Drugs 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
210000002216 heart Anatomy 0.000 description 3
210000003958 hematopoietic stem cell Anatomy 0.000 description 3
238000000265 homogenisation Methods 0.000 description 3
238000002657 hormone replacement therapy Methods 0.000 description 3
210000004408 hybridoma Anatomy 0.000 description 3
210000003559 hypertrophic chondrocyte Anatomy 0.000 description 3
238000003018 immunoassay Methods 0.000 description 3
230000006872 improvement Effects 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
238000011081 inoculation Methods 0.000 description 3
210000000629 knee joint Anatomy 0.000 description 3
230000004807 localization Effects 0.000 description 3
210000001165 lymph node Anatomy 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
230000009245 menopause Effects 0.000 description 3
230000002503 metabolic effect Effects 0.000 description 3
230000003278 mimic effect Effects 0.000 description 3
230000002438 mitochondrial effect Effects 0.000 description 3
238000002887 multiple sequence alignment Methods 0.000 description 3
210000003205 muscle Anatomy 0.000 description 3
230000004072 osteoblast differentiation Effects 0.000 description 3
210000004409 osteocyte Anatomy 0.000 description 3
239000001301 oxygen Substances 0.000 description 3
244000052769 pathogen Species 0.000 description 3
230000001717 pathogenic effect Effects 0.000 description 3
210000003668 pericyte Anatomy 0.000 description 3
210000003460 periosteum Anatomy 0.000 description 3
239000012071 phase Substances 0.000 description 3
229920002401 polyacrylamide Polymers 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
230000000750 progressive effect Effects 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
238000001742 protein purification Methods 0.000 description 3
238000007894 restriction fragment length polymorphism technique Methods 0.000 description 3
238000010839 reverse transcription Methods 0.000 description 3
239000002342 ribonucleoside Substances 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
238000012216 screening Methods 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
238000003196 serial analysis of gene expression Methods 0.000 description 3
230000035939 shock Effects 0.000 description 3
239000002904 solvent Substances 0.000 description 3
125000006850 spacer group Chemical group 0.000 description 3
210000000952 spleen Anatomy 0.000 description 3
210000001324 spliceosome Anatomy 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
150000003431 steroids Chemical class 0.000 description 3
239000000758 substrate Substances 0.000 description 3
230000004083 survival effect Effects 0.000 description 3
108010084272 syntrophin alpha1 Proteins 0.000 description 3
238000001890 transfection Methods 0.000 description 3
230000009466 transformation Effects 0.000 description 3
230000009261 transgenic effect Effects 0.000 description 3
238000011830 transgenic mouse model Methods 0.000 description 3
241000701161 unidentified adenovirus Species 0.000 description 3
210000004291 uterus Anatomy 0.000 description 3
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 3
235000005282 vitamin D3 Nutrition 0.000 description 3
239000011647 vitamin D3 Substances 0.000 description 3
229940021056 vitamin d3 Drugs 0.000 description 3
102100029077 3-hydroxy-3-methylglutaryl-coenzyme A reductase Human genes 0.000 description 2
101710158485 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
101710159080 Aconitate hydratase A Proteins 0.000 description 2
101710159078 Aconitate hydratase B Proteins 0.000 description 2
OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
229940122361 Bisphosphonate Drugs 0.000 description 2
102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
206010006187 Breast cancer Diseases 0.000 description 2
208000017667 Chronic Disease Diseases 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
108020004394 Complementary RNA Proteins 0.000 description 2
102100023768 Constitutive coactivator of PPAR-gamma-like protein 1 Human genes 0.000 description 2
241000761389 Copa Species 0.000 description 2
108010041986 DNA Vaccines Proteins 0.000 description 2
229940021995 DNA vaccine Drugs 0.000 description 2
102100034581 Dihydroorotase Human genes 0.000 description 2
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
108010069091 Dystrophin Proteins 0.000 description 2
102000001039 Dystrophin Human genes 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
102000048186 Endothelin-converting enzyme 1 Human genes 0.000 description 2
108030001679 Endothelin-converting enzyme 1 Proteins 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
108050001049 Extracellular proteins Proteins 0.000 description 2
108010067306 Fibronectins Proteins 0.000 description 2
102000016359 Fibronectins Human genes 0.000 description 2
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 2
101001048826 Homo sapiens Constitutive coactivator of PPAR-gamma-like protein 1 Proteins 0.000 description 2
101000968916 Homo sapiens Methylsterol monooxygenase 1 Proteins 0.000 description 2
101001077420 Homo sapiens Potassium voltage-gated channel subfamily H member 7 Proteins 0.000 description 2
101000864786 Homo sapiens Secreted frizzled-related protein 2 Proteins 0.000 description 2
101000911513 Homo sapiens Uncharacterized protein FAM215A Proteins 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
102000014429 Insulin-like growth factor Human genes 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
102000019298 Lipocalin Human genes 0.000 description 2
108050006654 Lipocalin Proteins 0.000 description 2
102100027159 Membrane primary amine oxidase Human genes 0.000 description 2
101710132836 Membrane primary amine oxidase Proteins 0.000 description 2
102100021091 Methylsterol monooxygenase 1 Human genes 0.000 description 2
JKWKMORAXJQQSR-MOPIKTETSA-N Nandrolone Decanoate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC2 JKWKMORAXJQQSR-MOPIKTETSA-N 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
108020004711 Nucleic Acid Probes Proteins 0.000 description 2
206010031243 Osteogenesis imperfecta Diseases 0.000 description 2
108010077077 Osteonectin Proteins 0.000 description 2
102000009890 Osteonectin Human genes 0.000 description 2
102000004264 Osteopontin Human genes 0.000 description 2
108010081689 Osteopontin Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
229930040373 Paraformaldehyde Natural products 0.000 description 2
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
102100025133 Potassium voltage-gated channel subfamily H member 7 Human genes 0.000 description 2
102100038567 Properdin Human genes 0.000 description 2
108010005642 Properdin Proteins 0.000 description 2
108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
238000002123 RNA extraction Methods 0.000 description 2
239000003391 RNA probe Substances 0.000 description 2
102000044126 RNA-Binding Proteins Human genes 0.000 description 2
101710105008 RNA-binding protein Proteins 0.000 description 2
241000700157 Rattus norvegicus Species 0.000 description 2
102000004389 Ribonucleoproteins Human genes 0.000 description 2
108010081734 Ribonucleoproteins Proteins 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
102100030054 Secreted frizzled-related protein 2 Human genes 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
241000700584 Simplexvirus Species 0.000 description 2
241001481798 Stochomys longicaudatus Species 0.000 description 2
108010090804 Streptavidin Proteins 0.000 description 2
MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine kinase Proteins 0.000 description 2
108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
102100026728 Uncharacterized protein FAM215A Human genes 0.000 description 2
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
229930003316 Vitamin D Natural products 0.000 description 2
230000035508 accumulation Effects 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
238000004220 aggregation Methods 0.000 description 2
230000032683 aging Effects 0.000 description 2
239000000556 agonist Substances 0.000 description 2
229940062527 alendronate Drugs 0.000 description 2
239000005557 antagonist Substances 0.000 description 2
239000000427 antigen Substances 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
235000006708 antioxidants Nutrition 0.000 description 2
238000003782 apoptosis assay Methods 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
210000000270 basal cell Anatomy 0.000 description 2
239000002585 base Substances 0.000 description 2
239000011324 bead Substances 0.000 description 2
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
150000004663 bisphosphonates Chemical class 0.000 description 2
210000001772 blood platelet Anatomy 0.000 description 2
230000037118 bone strength Effects 0.000 description 2
230000008416 bone turnover Effects 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
239000007894 caplet Substances 0.000 description 2
239000000969 carrier Substances 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
229960004926 chlorobutanol Drugs 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000013270 controlled release Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000001351 cycling effect Effects 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
230000034994 death Effects 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
230000002950 deficient Effects 0.000 description 2
239000003599 detergent Substances 0.000 description 2
238000002405 diagnostic procedure Methods 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000000378 dietary effect Effects 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
230000029087 digestion Effects 0.000 description 2
210000002249 digestive system Anatomy 0.000 description 2
230000003467 diminishing effect Effects 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
230000013020 embryo development Effects 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
230000035194 endochondral ossification Effects 0.000 description 2
210000003238 esophagus Anatomy 0.000 description 2
229960005309 estradiol Drugs 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
238000011049 filling Methods 0.000 description 2
235000019634 flavors Nutrition 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
108020001507 fusion proteins Proteins 0.000 description 2
210000001035 gastrointestinal tract Anatomy 0.000 description 2
238000001641 gel filtration chromatography Methods 0.000 description 2
238000001476 gene delivery Methods 0.000 description 2
238000010363 gene targeting Methods 0.000 description 2
238000002695 general anesthesia Methods 0.000 description 2
239000008103 glucose Substances 0.000 description 2
210000003128 head Anatomy 0.000 description 2
230000005802 health problem Effects 0.000 description 2
229960002897 heparin Drugs 0.000 description 2
229920000669 heparin Polymers 0.000 description 2
230000013632 homeostatic process Effects 0.000 description 2
238000005286 illumination Methods 0.000 description 2
230000001976 improved effect Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
239000012678 infectious agent Substances 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
230000002757 inflammatory effect Effects 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
208000014674 injury Diseases 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
239000000543 intermediate Substances 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
238000011835 investigation Methods 0.000 description 2
231100000636 lethal dose Toxicity 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
239000002502 liposome Substances 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
210000003563 lymphoid tissue Anatomy 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
210000004373 mandible Anatomy 0.000 description 2
229920000609 methyl cellulose Polymers 0.000 description 2
239000001923 methylcellulose Substances 0.000 description 2
239000003607 modifier Substances 0.000 description 2
229960001935 nandrolone decanoate Drugs 0.000 description 2
239000002853 nucleic acid probe Substances 0.000 description 2
210000001706 olfactory mucosa Anatomy 0.000 description 2
238000005457 optimization Methods 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
230000001599 osteoclastic effect Effects 0.000 description 2
210000005009 osteogenic cell Anatomy 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
229920002866 paraformaldehyde Polymers 0.000 description 2
230000037361 pathway Effects 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
150000003904 phospholipids Chemical class 0.000 description 2
230000037081 physical activity Effects 0.000 description 2
239000013600 plasmid vector Substances 0.000 description 2
230000008092 positive effect Effects 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
239000000843 powder Substances 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
230000005522 programmed cell death Effects 0.000 description 2
208000037821 progressive disease Diseases 0.000 description 2
230000000770 proinflammatory effect Effects 0.000 description 2
238000011321 prophylaxis Methods 0.000 description 2
KAQKFAOMNZTLHT-OZUDYXHBSA-N prostaglandin I2 Chemical compound O1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-N 0.000 description 2
230000026447 protein localization Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
239000011535 reaction buffer Substances 0.000 description 2
238000011084 recovery Methods 0.000 description 2
102000037983 regulatory factors Human genes 0.000 description 2
108091008025 regulatory factors Proteins 0.000 description 2
238000009877 rendering Methods 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
230000002207 retinal effect Effects 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
210000003935 rough endoplasmic reticulum Anatomy 0.000 description 2
210000003079 salivary gland Anatomy 0.000 description 2
238000000926 separation method Methods 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
230000009645 skeletal growth Effects 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
210000000813 small intestine Anatomy 0.000 description 2
ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
206010041569 spinal fracture Diseases 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
230000009469 supplementation Effects 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
229940037128 systemic glucocorticoids Drugs 0.000 description 2
238000010998 test method Methods 0.000 description 2
229940104230 thymidine Drugs 0.000 description 2
230000005758 transcription activity Effects 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
230000007704 transition Effects 0.000 description 2
239000001226 triphosphate Substances 0.000 description 2
235000011178 triphosphate Nutrition 0.000 description 2
230000009452 underexpressoin Effects 0.000 description 2
241001529453 unidentified herpesvirus Species 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
210000003932 urinary bladder Anatomy 0.000 description 2
238000002255 vaccination Methods 0.000 description 2
235000019166 vitamin D Nutrition 0.000 description 2
239000011710 vitamin D Substances 0.000 description 2
150000003710 vitamin D derivatives Chemical class 0.000 description 2
229940046008 vitamin d Drugs 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
210000000707 wrist Anatomy 0.000 description 2
NLIVDORGVGAOOJ-MAHBNPEESA-M xylene cyanol Chemical compound [Na+].C1=C(C)C(NCC)=CC=C1C(\C=1C(=CC(OS([O-])=O)=CC=1)OS([O-])=O)=C\1C=C(C)\C(=[NH+]/CC)\C=C/1 NLIVDORGVGAOOJ-MAHBNPEESA-M 0.000 description 2
BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
LVXLCZPTUBQNHH-UHFFFAOYSA-N 2-amino-5-[[1-(carboxymethylamino)-3-(2-chloro-1,1,2-trifluoroethyl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)C(N)CCC(=O)NC(CSC(F)(F)C(F)Cl)C(=O)NCC(O)=O LVXLCZPTUBQNHH-UHFFFAOYSA-N 0.000 description 1
108020005345 3' Untranslated Regions Proteins 0.000 description 1
FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
101710131943 40S ribosomal protein S3a Proteins 0.000 description 1
108020003589 5' Untranslated Regions Proteins 0.000 description 1
102100022464 5'-nucleotidase Human genes 0.000 description 1
102100023990 60S ribosomal protein L17 Human genes 0.000 description 1
108091022879 ADAMTS Proteins 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
239000004925 Acrylic resin Substances 0.000 description 1
229920000178 Acrylic resin Polymers 0.000 description 1
208000030090 Acute Disease Diseases 0.000 description 1
102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
241000710929 Alphavirus Species 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
244000105975 Antidesma platyphyllum Species 0.000 description 1
108020004491 Antisense DNA Proteins 0.000 description 1
102000004888 Aquaporin 1 Human genes 0.000 description 1
108090001004 Aquaporin 1 Proteins 0.000 description 1
102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
101710133654 C-5 sterol desaturase Proteins 0.000 description 1
241001164374 Calyx Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108091006146 Channels Proteins 0.000 description 1
102100033601 Collagen alpha-1(I) chain Human genes 0.000 description 1
102100036213 Collagen alpha-2(I) chain Human genes 0.000 description 1
206010010144 Completed suicide Diseases 0.000 description 1
108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 1
102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
102000010831 Cytoskeletal Proteins Human genes 0.000 description 1
108010037414 Cytoskeletal Proteins Proteins 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
108010092160 Dactinomycin Proteins 0.000 description 1
101710111046 Delta(7)-sterol 5(6)-desaturase Proteins 0.000 description 1
102100038199 Desmoplakin Human genes 0.000 description 1
SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
101800000620 Disintegrin-like Proteins 0.000 description 1
108010024212 E-Selectin Proteins 0.000 description 1
102100023471 E-selectin Human genes 0.000 description 1
101150044894 ER gene Proteins 0.000 description 1
241000257465 Echinoidea Species 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
241000991587 Enterovirus C Species 0.000 description 1
DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
102100026761 Eukaryotic translation initiation factor 5A-1 Human genes 0.000 description 1
208000006168 Ewing Sarcoma Diseases 0.000 description 1
102000008857 Ferritin Human genes 0.000 description 1
108050000784 Ferritin Proteins 0.000 description 1
238000008416 Ferritin Methods 0.000 description 1
102100026561 Filamin-A Human genes 0.000 description 1
101710091743 Filamin-A Proteins 0.000 description 1
102000005698 Frizzled receptors Human genes 0.000 description 1
108010045438 Frizzled receptors Proteins 0.000 description 1
101150098893 GEM gene Proteins 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
208000003098 Ganglion Cysts Diseases 0.000 description 1
BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
229920002527 Glycogen Polymers 0.000 description 1
108010001483 Glycogen Synthase Proteins 0.000 description 1
OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
208000023803 Hip injury Diseases 0.000 description 1
101100434309 Homo sapiens ADA gene Proteins 0.000 description 1
101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 description 1
101000883444 Homo sapiens Desmoplakin Proteins 0.000 description 1
101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 1
101100231743 Homo sapiens HPRT1 gene Proteins 0.000 description 1
101000691574 Homo sapiens Junction plakoglobin Proteins 0.000 description 1
101000864743 Homo sapiens Secreted frizzled-related protein 1 Proteins 0.000 description 1
241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
244000025221 Humulus lupulus Species 0.000 description 1
235000008694 Humulus lupulus Nutrition 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
208000037147 Hypercalcaemia Diseases 0.000 description 1
208000013038 Hypocalcemia Diseases 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
108010041014 Integrin alpha5 Proteins 0.000 description 1
108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 1
102000003996 Interferon-beta Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
108090001007 Interleukin-8 Proteins 0.000 description 1
102000004890 Interleukin-8 Human genes 0.000 description 1
102100026153 Junction plakoglobin Human genes 0.000 description 1
LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
101710137448 Lathosterol oxidase Proteins 0.000 description 1
102100037199 Lathosterol oxidase Human genes 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
241001625930 Luria Species 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
101000870233 Manduca sexta Diuretic hormone 2 Proteins 0.000 description 1
108091060294 Messenger RNP Proteins 0.000 description 1
102000005741 Metalloproteases Human genes 0.000 description 1
108010006035 Metalloproteases Proteins 0.000 description 1
208000037848 Metastatic bone disease Diseases 0.000 description 1
108020005196 Mitochondrial DNA Proteins 0.000 description 1
108010058682 Mitochondrial Proteins Proteins 0.000 description 1
102000006404 Mitochondrial Proteins Human genes 0.000 description 1
102000015728 Mucins Human genes 0.000 description 1
108010063954 Mucins Proteins 0.000 description 1
108700005084 Multigene Family Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101100219978 Mus musculus Ccn2 gene Proteins 0.000 description 1
101100317378 Mus musculus Wnt3 gene Proteins 0.000 description 1
CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
206010029260 Neuroblastoma Diseases 0.000 description 1
102100035405 Neutrophil gelatinase-associated lipocalin Human genes 0.000 description 1
101710147507 Neutrophil gelatinase-associated lipocalin Proteins 0.000 description 1
102100021010 Nucleolin Human genes 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
102000004067 Osteocalcin Human genes 0.000 description 1
108090000573 Osteocalcin Proteins 0.000 description 1
208000001164 Osteoporotic Fractures Diseases 0.000 description 1
102000000470 PDZ domains Human genes 0.000 description 1
108050008994 PDZ domains Proteins 0.000 description 1
102000003982 Parathyroid hormone Human genes 0.000 description 1
108090000445 Parathyroid hormone Proteins 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
244000046052 Phaseolus vulgaris Species 0.000 description 1
235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
102000000571 Phospholipases A Human genes 0.000 description 1
108010002176 Phospholipases A Proteins 0.000 description 1
102000006447 Phospholipases A2 Human genes 0.000 description 1
108010058864 Phospholipases A2 Proteins 0.000 description 1
241000709664 Picornaviridae Species 0.000 description 1
108010079304 Picornavirus picornain 2A Proteins 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
241000932075 Priacanthus hamrur Species 0.000 description 1
101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
102100021923 Prolow-density lipoprotein receptor-related protein 1 Human genes 0.000 description 1
102000048176 Prostaglandin-D synthases Human genes 0.000 description 1
108030003866 Prostaglandin-D synthases Proteins 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
206010071368 Psychological trauma Diseases 0.000 description 1
239000013614 RNA sample Substances 0.000 description 1
230000004570 RNA-binding Effects 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
101000897038 Rattus norvegicus Nucleotide pyrophosphatase Proteins 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108700005075 Regulator Genes Proteins 0.000 description 1
241000219061 Rheum Species 0.000 description 1
102100037968 Ribonuclease inhibitor Human genes 0.000 description 1
108010000605 Ribosomal Proteins Proteins 0.000 description 1
102000002278 Ribosomal Proteins Human genes 0.000 description 1
108700008242 S-(2-chloro-1,1,2-trifluoroethyl)glutathione Proteins 0.000 description 1
MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
108091006296 SLC2A1 Proteins 0.000 description 1
101100246066 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PUB1 gene Proteins 0.000 description 1
102100030058 Secreted frizzled-related protein 1 Human genes 0.000 description 1
206010039984 Senile osteoporosis Diseases 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
WBAXJMCUFIXCNI-WDSKDSINSA-N Ser-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WBAXJMCUFIXCNI-WDSKDSINSA-N 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
235000019486 Sunflower oil Nutrition 0.000 description 1
208000005400 Synovial Cyst Diseases 0.000 description 1
102000004402 Syntrophin Human genes 0.000 description 1
108090000916 Syntrophin Proteins 0.000 description 1
108091005735 TGF-beta receptors Proteins 0.000 description 1
101150003725 TK gene Proteins 0.000 description 1
102000004357 Transferases Human genes 0.000 description 1
108090000992 Transferases Proteins 0.000 description 1
108010009583 Transforming Growth Factors Proteins 0.000 description 1
102000009618 Transforming Growth Factors Human genes 0.000 description 1
102400000716 Transforming growth factor beta-1 Human genes 0.000 description 1
101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108010020713 Tth polymerase Proteins 0.000 description 1
102000014384 Type C Phospholipases Human genes 0.000 description 1
108010079194 Type C Phospholipases Proteins 0.000 description 1
108010046334 Urease Proteins 0.000 description 1
101710102828 Vesicle-associated protein Proteins 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
208000037919 acquired disease Diseases 0.000 description 1
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000009056 active transport Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
229960001570 ademetionine Drugs 0.000 description 1
108010084938 adenovirus receptor Proteins 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000004479 aerosol dispenser Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
OGSPWJRAVKPPFI-UHFFFAOYSA-M alendronate(1-) Chemical compound NCCCC(O)(P(O)(O)=O)P(O)([O-])=O OGSPWJRAVKPPFI-UHFFFAOYSA-M 0.000 description 1
239000003513 alkali Substances 0.000 description 1
150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 description 1
101150087698 alpha gene Proteins 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
239000003263 anabolic agent Substances 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000002424 anti-apoptotic effect Effects 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
239000003816 antisense DNA Substances 0.000 description 1
230000001640 apoptogenic effect Effects 0.000 description 1
101150031224 app gene Proteins 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
238000003491 array Methods 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
210000004507 artificial chromosome Anatomy 0.000 description 1
230000001174 ascending effect Effects 0.000 description 1
230000003305 autocrine Effects 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
210000002469 basement membrane Anatomy 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229960000686 benzalkonium chloride Drugs 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
230000008238 biochemical pathway Effects 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000033558 biomineral tissue development Effects 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
230000036765 blood level Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
210000000621 bronchi Anatomy 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
235000020964 calcitriol Nutrition 0.000 description 1
239000011612 calcitriol Substances 0.000 description 1
229960005084 calcitriol Drugs 0.000 description 1
GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 1
230000004094 calcium homeostasis Effects 0.000 description 1
230000003185 calcium uptake Effects 0.000 description 1
230000028956 calcium-mediated signaling Effects 0.000 description 1
230000000711 cancerogenic effect Effects 0.000 description 1
229960001631 carbomer Drugs 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
229940105329 carboxymethylcellulose Drugs 0.000 description 1
231100000357 carcinogen Toxicity 0.000 description 1
239000003183 carcinogenic agent Substances 0.000 description 1
230000002612 cardiopulmonary effect Effects 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000009134 cell regulation Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 description 1
229960002286 clodronic acid Drugs 0.000 description 1
238000012411 cloning technique Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229940096422 collagen type i Drugs 0.000 description 1
230000000112 colonic effect Effects 0.000 description 1
230000009918 complex formation Effects 0.000 description 1
235000008504 concentrate Nutrition 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
239000003636 conditioned culture medium Substances 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
238000007596 consolidation process Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
239000002385 cottonseed oil Substances 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
230000000120 cytopathologic effect Effects 0.000 description 1
230000003436 cytoskeletal effect Effects 0.000 description 1
210000004292 cytoskeleton Anatomy 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
229960000640 dactinomycin Drugs 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000001934 delay Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
230000008021 deposition Effects 0.000 description 1
210000001047 desmosome Anatomy 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
235000001434 dietary modification Nutrition 0.000 description 1
FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000000975 dye Substances 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000006353 environmental stress Effects 0.000 description 1
239000003256 environmental substance Substances 0.000 description 1
230000002327 eosinophilic effect Effects 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
210000003560 epithelium corneal Anatomy 0.000 description 1
235000020774 essential nutrients Nutrition 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000002834 estrogen receptor modulator Substances 0.000 description 1
230000001076 estrogenic effect Effects 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
229940009626 etidronate Drugs 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000011124 ex vivo culture Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
238000001400 expression cloning Methods 0.000 description 1
210000003414 extremity Anatomy 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
230000037406 food intake Effects 0.000 description 1
ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
229960002963 ganciclovir Drugs 0.000 description 1
IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
230000000762 glandular Effects 0.000 description 1
229940096919 glycogen Drugs 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
239000003163 gonadal steroid hormone Substances 0.000 description 1
239000008187 granular material Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
235000009424 haa Nutrition 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
210000003780 hair follicle Anatomy 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
210000000777 hematopoietic system Anatomy 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
230000009215 host defense mechanism Effects 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
229940071676 hydroxypropylcellulose Drugs 0.000 description 1
230000000148 hypercalcaemia Effects 0.000 description 1
208000030915 hypercalcemia disease Diseases 0.000 description 1
230000000121 hypercalcemic effect Effects 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
230000002390 hyperplastic effect Effects 0.000 description 1
230000001969 hypertrophic effect Effects 0.000 description 1
230000000705 hypocalcaemia Effects 0.000 description 1
230000006164 hypusine formation Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000003053 immunization Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
239000000411 inducer Substances 0.000 description 1
230000036512 infertility Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
102000028416 insulin-like growth factor binding Human genes 0.000 description 1
108091022911 insulin-like growth factor binding Proteins 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
230000026045 iodination Effects 0.000 description 1
238000006192 iodination reaction Methods 0.000 description 1
230000001678 irradiating effect Effects 0.000 description 1
208000023589 ischemic disease Diseases 0.000 description 1
239000007951 isotonicity adjuster Substances 0.000 description 1
238000002372 labelling Methods 0.000 description 1
229940058690 lanosterol Drugs 0.000 description 1
CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
238000007834 ligase chain reaction Methods 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
239000008297 liquid dosage form Substances 0.000 description 1
244000144972 livestock Species 0.000 description 1
230000008376 long-term health Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000006210 lotion Substances 0.000 description 1
101150084157 lrp-1 gene Proteins 0.000 description 1
210000005210 lymphoid organ Anatomy 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
210000005075 mammary gland Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
210000005033 mesothelial cell Anatomy 0.000 description 1
230000037353 metabolic pathway Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
210000004088 microvessel Anatomy 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
108091064355 mitochondrial RNA Proteins 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
230000000394 mitotic effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000001823 molecular biology technique Methods 0.000 description 1
210000004487 mononuclear osteoclast Anatomy 0.000 description 1
210000002864 mononuclear phagocyte Anatomy 0.000 description 1
230000000921 morphogenic effect Effects 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
230000004899 motility Effects 0.000 description 1
229940051875 mucins Drugs 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
210000000066 myeloid cell Anatomy 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
210000003098 myoblast Anatomy 0.000 description 1
210000002850 nasal mucosa Anatomy 0.000 description 1
230000009826 neoplastic cell growth Effects 0.000 description 1
230000001613 neoplastic effect Effects 0.000 description 1
210000003757 neuroblast Anatomy 0.000 description 1
230000004770 neurodegeneration Effects 0.000 description 1
208000015122 neurodegenerative disease Diseases 0.000 description 1
210000004498 neuroglial cell Anatomy 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000024121 nodulation Effects 0.000 description 1
239000002687 nonaqueous vehicle Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
210000001331 nose Anatomy 0.000 description 1
230000030147 nuclear export Effects 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
108010044762 nucleolin Proteins 0.000 description 1
108010027581 nucleoside triphosphate pyrophosphatase Proteins 0.000 description 1
108010067588 nucleotide pyrophosphatase Proteins 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
239000002674 ointment Substances 0.000 description 1
XDUHQPOXLUAVEE-BPMMELMSSA-N oleoyl-CoA Chemical class O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCC\C=C/CCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 XDUHQPOXLUAVEE-BPMMELMSSA-N 0.000 description 1
229940046166 oligodeoxynucleotide Drugs 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
239000006186 oral dosage form Substances 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
208000002865 osteopetrosis Diseases 0.000 description 1
201000001937 osteoporosis-pseudoglioma syndrome Diseases 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
230000036542 oxidative stress Effects 0.000 description 1
239000006179 pH buffering agent Substances 0.000 description 1
230000000849 parathyroid Effects 0.000 description 1
239000000199 parathyroid hormone Substances 0.000 description 1
229960001319 parathyroid hormone Drugs 0.000 description 1
231100000915 pathological change Toxicity 0.000 description 1
230000036285 pathological change Effects 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
229960003742 phenol Drugs 0.000 description 1
230000009120 phenotypic response Effects 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
108010024226 placental ribonuclease inhibitor Proteins 0.000 description 1
210000004180 plasmocyte Anatomy 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000000583 progesterone congener Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 description 1
YIBNHAJFJUQSRA-YNNPMVKQSA-N prostaglandin H2 Chemical compound C1[C@@H]2OO[C@H]1[C@H](/C=C/[C@@H](O)CCCCC)[C@H]2C\C=C/CCCC(O)=O YIBNHAJFJUQSRA-YNNPMVKQSA-N 0.000 description 1
BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 description 1
108010043671 prostatic acid phosphatase Proteins 0.000 description 1
235000019419 proteases Nutrition 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000012514 protein characterization Methods 0.000 description 1
238000002331 protein detection Methods 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
239000008213 purified water Substances 0.000 description 1
238000011155 quantitative monitoring Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
239000013074 reference sample Substances 0.000 description 1
230000025915 regulation of apoptotic process Effects 0.000 description 1
230000014493 regulation of gene expression Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000010410 reperfusion Effects 0.000 description 1
230000000754 repressing effect Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
210000001533 respiratory mucosa Anatomy 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
235000020944 retinol Nutrition 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
108010025578 ribosomal protein L17 Proteins 0.000 description 1
101150106848 rnp-2 gene Proteins 0.000 description 1
101150050176 rnp1 gene Proteins 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
239000004576 sand Substances 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000013341 scale-up Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
238000005204 segregation Methods 0.000 description 1
210000002863 seminiferous tubule Anatomy 0.000 description 1
238000011896 sensitive detection Methods 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
210000000717 sertoli cell Anatomy 0.000 description 1
108010026333 seryl-proline Proteins 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
230000011664 signaling Effects 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
229910001415 sodium ion Inorganic materials 0.000 description 1
239000001433 sodium tartrate Substances 0.000 description 1
229960002167 sodium tartrate Drugs 0.000 description 1
235000011004 sodium tartrates Nutrition 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000007909 solid dosage form Substances 0.000 description 1
239000008247 solid mixture Substances 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
238000011895 specific detection Methods 0.000 description 1
229940063673 spermidine Drugs 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
BBNRSHIAFWOPAK-UHFFFAOYSA-L steroid d Chemical compound [Na+].[Na+].O1C2CC3C4CCC5CC(OS([O-])(=O)=O)C(OS([O-])(=O)=O)CC5(C)C4CCC3(C)C2C2(C)OC1(CCC)OC2CC1(C(C)C)CC1C BBNRSHIAFWOPAK-UHFFFAOYSA-L 0.000 description 1
239000012089 stop solution Substances 0.000 description 1
239000002438 stress hormone Substances 0.000 description 1
210000002536 stromal cell Anatomy 0.000 description 1
230000004960 subcellular localization Effects 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000002600 sunflower oil Substances 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000009747 swallowing Effects 0.000 description 1
230000005062 synaptic transmission Effects 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
229960003604 testosterone Drugs 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
210000000115 thoracic cavity Anatomy 0.000 description 1
238000004448 titration Methods 0.000 description 1
210000002105 tongue Anatomy 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
210000000626 ureter Anatomy 0.000 description 1
210000002229 urogenital system Anatomy 0.000 description 1
210000003741 urothelium Anatomy 0.000 description 1
230000002792 vascular Effects 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
238000009736 wetting Methods 0.000 description 1
230000037314 wound repair Effects 0.000 description 1
239000000230 xanthan gum Substances 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
235000010493 xanthan gum Nutrition 0.000 description 1
229940082509 xanthan gum Drugs 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1